Annual report for Fortis Healthcare Ltd. for FY-2020
17-06-2020
Fortis Healthcare reports fall in hospital occupancy due to Covid-19 crisis
The company's diagnostics business also witnessed 75 per cent drop in volumes in April. Patients choose to postpone elective procedures while there was a significant drop in footfalls in OPD12-06-2020
FORTIS HEALTHCARE LTD. - 532843 - Disclosure On Impact Of COVID-19 Pandemic On The Business And Operations Of The Company
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with circular SEBI/HO/CFD/CMD1/CIR/P/2020/84, dated May 20, 2020, please find attached the impact of COVID-19 on the business and operations of the Company. This is for your information and records.11-06-2020
FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/06/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, June 17, 2020 to, inter-alia, consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2020. Further, in continuation to our letter ref. FHL/SEC/2019-20 dated March 30, 2020 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till June 19, 2020. This is for your information and records please.10-06-2020
FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate
Dear Sir(s), In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Mr. Dilip Kadambi (DIN:02148022), as an Additional Director (Non-Executive) of the Company with effect from June 4, 2020. Brief Profile of Mr. Dilip Kadambi is attached as Annexure 1. Further, there is no inter-se relationship between Mr. Dilip Kadambi and other Directors. Mr. Dilip Kadambi has declared that he is not debarred from accessing the capital markets and / or restrained from holding any position / office of Director in a Company pursuant to order of SEBI or any other such authority. Further, Mr. Low Soon Teck (DIN: 01880497), Non-Executive Director of the Company, has resigned from the Directorship of the Company with effect from June 4, 2020. This is for your information and records please.04-06-2020
Singapore court dismisses appeal by Singh Bros against Rs3500 cr arbitral award
The Singapore court has dismissed appeals made by the former Fortis promoters duo challenging a 2016 arbitral award of Rs 3,500 crore against them and29-05-2020
FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you the Company has today issued a postal ballot notice to its Members for seeking approval of the members by way of Special Resolution. A copy of the postal ballot notice along with ballot form is enclosed for kind reference.28-05-2020
FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Dear Sir(s), In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you that Board of Directors of the Company at their meeting held today, considered and recommended to the shareholders further investment as may be determined by the Board of Directors basis the fair value, in wholly owned subsidiary Companies viz Escorts Heart Institute and Research Centre Limited (EHIRCL), Hiranandani Healthcare Private Limited (HHPL) and Fortis Hospitals Limited (FHsL). The detailed disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are attached herewith. This is for your kind information and records purposes.26-05-2020
Separate infra needed for Covid-19 patients with other ailments: Fortis CEO
The hospital has chosen not to cut salaries of frontline health workers even as its looks to implement cost saving measures03-05-2020
FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you that Board of Directors of the Company at their meeting held today, considered and recommended to the Shareholders of the Company the candidature of Ms. Shailaja Chandra (DIN: 03320688 and aged 75 years) to be appointed as an Independent Director of the Company for a period of five years, not liable to retire by rotation, subject to approval of the shareholders of the Company. In terms of Regulations 17(1A) of SEBI LODR, the appointment of Ms. Shailaja Chandra will be effective from the date of approval of the Shareholders of the Company by way of special resolution. Brief Profile of Ms. Shailaja Chandra is attached herewith and marked as Annexure 1. The detailed disclosure in this regard is attached. This is for your information and records please.30-04-2020